The customer complained of 4 patient samples that tested negative for elecsys rubella igg (roche igg) immunoassay on cobas e 411 immunoassay analyzer were confirmed positive by western blot testing.The customer was contacted by a separate laboratory about a patient who tested negative for rubella igg using a roche method who was testing positive in their laboratory.The customer took all the sera samples that were found to be negative since (b)(6) 2016 and sent them to another laboratory for testing using diasorin method.Of 5 patient samples that were found to be negative, 4 were confirmed as being initially reported as false negatives and are a reportable malfunction.No specific units were provided.The diasorin cutoff is 12 while the roche igg cutoff is 10.The siemens cutoff was not provided.Patient #1 had a roche igg result of 6 (negative), a diasorin result of 35 (positive), a siemens result of 18, and a positive western blot.Patient #2 had a roche igg result of 6 (negative), a diasorin result of 23 (positive), a siemens result of 23, and a positive western blot.Patient #3 had a roche igg result of 3 (negative), a diasorin result of 32 (positive), a siemens result of 13.7, and a positive western blot.Patient #4 had a roche igg result of 8 (negative), a diasorin result of <8 (negative), a siemens result of intermediate with an "ac anti-e1 positive", and a positive western blot.The patients were pregnant woman who all gave birth at the customer¿s hospital.No other patient information was provided.The erroneous results were reported outside of the laboratory.The results from the western blot testing were deemed to be correct.There was no allegation of an adverse event.The cobas e411 serial (b)(4).The investigation is still ongoing.
|